June 30, 2016
Novocure Announces $75 Million Drawdown under Its Term Loan Agreement through Pharmakon Advisors
Non-dilutive financing enhances financial strength Non-dilutive financing enhances financial strength June 30, 2016 04:00 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it has provided notice to draw the remaining $75… Read More
learn more
June 30, 2016
Novocure Announces $75 Million Drawdown under Its Term Loan Agreement through Pharmakon Advisors
Non-dilutive financing enhances financial strength Non-dilutive financing enhances financial strength June 30, 2016 04:00 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it has provided notice to draw the remaining $75… Read More
learn more
June 30, 2016
Novocure Announces $75 Million Drawdown under Its Term Loan Agreement through Pharmakon Advisors
Non-dilutive financing enhances financial strength Non-dilutive financing enhances financial strength June 30, 2016 04:00 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it has provided notice to draw the remaining $75… Read More
learn more
June 30, 2016
Novocure to Report Second Quarter 2016 Financial Results
June 30, 2016 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2016 on Thursday, July 28, 2016 at 6:30 a.m. EDT before the open of… Read More
learn more
June 30, 2016
Novocure to Report Second Quarter 2016 Financial Results
June 30, 2016 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2016 on Thursday, July 28, 2016 at 6:30 a.m. EDT before the open of… Read More
learn more
June 30, 2016
Novocure to Report Second Quarter 2016 Financial Results
June 30, 2016 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2016 on Thursday, July 28, 2016 at 6:30 a.m. EDT before the open of… Read More
learn more
June 8, 2016
Novocure to Present at JMP Securities 2016 Life Sciences Conference
June 08, 2016 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced that Mike Ambrogi, Novocure’s Chief Operating Officer, will present at the JMP Securities 2016 Life Sciences Conference in New York. Mr. Ambrogi will present… Read More
learn more
June 8, 2016
Novocure to Present at JMP Securities 2016 Life Sciences Conference
June 08, 2016 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced that Mike Ambrogi, Novocure’s Chief Operating Officer, will present at the JMP Securities 2016 Life Sciences Conference in New York. Mr. Ambrogi will present… Read More
learn more
June 8, 2016
Novocure to Present at JMP Securities 2016 Life Sciences Conference
June 08, 2016 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced that Mike Ambrogi, Novocure’s Chief Operating Officer, will present at the JMP Securities 2016 Life Sciences Conference in New York. Mr. Ambrogi will present… Read More
learn more
